Your session is about to expire
← Back to Search
EHR-Based Approach for Reducing Medication Dosing Errors
N/A
Recruiting
Led By H. Shonna Yin, MD, MS
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 4 weeks of index visit (visit 1)
Awards & highlights
Study Summary
This trial will study whether an automated electronic health record (EHR)-based intervention that uses e-prescriptions can improve pharmacy dispensing practices and reduce parent dosing errors. The study will be conducted with English- and Spanish-speaking parents of children who are prescribed oral liquid medications in the pediatric emergency room, outpatient general pediatric clinic, and pediatric subspecialty clinics of 2 New York City hospital systems.
Who is the study for?
This trial is for English or Spanish-speaking parents or guardians over 18 years old, who are the primary caregivers of children aged ≤8 years prescribed liquid medications in specific New York City hospitals. Participants must have a smartphone and be willing to participate. Pharmacists involved must dispense medication to study participants.Check my eligibility
What is being tested?
The trial tests an EHR-based intervention aimed at helping pharmacists stick to mL-only dosing instructions and provide appropriate dosing tools, with the goal of reducing parental dosing errors with children's liquid medicines.See study design
What are the potential side effects?
Since this study focuses on improving dispensing practices rather than testing new medications, it does not directly involve medical side effects. However, there may be indirect effects related to changes in how medicine doses are managed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 4 weeks of index visit (visit 1)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 4 weeks of index visit (visit 1)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caregiver Dosing Error
Caregiver Large Dosing Error
Pharmacy Provision of Optimal Dosing Tool
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Post-Implementation - EHR-Based ApproachExperimental Treatment1 Intervention
Group II: Pre-Implementation - Usual CareActive Control1 Intervention
In pre-implementation phase, patient e-Rxs will be generated by the EHR in the usual fashion.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,374 Previous Clinical Trials
840,257 Total Patients Enrolled
Food and Drug Administration (FDA)FED
174 Previous Clinical Trials
1,333,192 Total Patients Enrolled
H. Shonna Yin, MD, MSPrincipal InvestigatorNYU Langone Health
3 Previous Clinical Trials
3,101 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a hearing problem that has not been fixed or corrected.You have reported having difficulty seeing clearly.
Research Study Groups:
This trial has the following groups:- Group 1: Pre-Implementation - Usual Care
- Group 2: Post-Implementation - EHR-Based Approach
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger